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Abstract
Background: Since most published articles comparing the performance of artificial neural network (ANN) models and
logistic regression (LR) models for predicting hepatocellular carcinoma (HCC) outcomes used only a single dataset, the
essential issue of internal validity (reproducibility) of the models has not been addressed. The study purposes to validate the
use of ANN model for predicting in-hospital mortality in HCC surgery patients in Taiwan and to compare the predictive
accuracy of ANN with that of LR model.
Methodology/Principal Findings: Patients who underwent a HCC surgery during the period from 1998 to 2009 were
included in the study. This study retrospectively compared 1,000 pairs of LR and ANN models based on initial clinical data
for 22,926 HCC surgery patients. For each pair of ANN and LR models, the area under the receiver operating characteristic
(AUROC) curves, Hosmer-Lemeshow (H-L) statistics and accuracy rate were calculated and compared using paired T-tests. A
global sensitivity analysis was also performed to assess the relative significance of input parameters in the system model
and the relative importance of variables. Compared to the LR models, the ANN models had a better accuracy rate in 97.28%
of cases, a better H-L statistic in 41.18% of cases, and a better AUROC curve in 84.67% of cases. Surgeon volume was the
most influential (sensitive) parameter affecting in-hospital mortality followed by age and lengths of stay.
Conclusions/Significance: In comparison with the conventional LR model, the ANN model in the study was more accurate
in predicting in-hospital mortality and had higher overall performance indices. Further studies of this model may consider
the effect of a more detailed database that includes complications and clinical examination findings as well as more detailed
outcome data.
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Introduction
Hepatocellular carcinoma (HCC) is prevalent in regions of Asia,
the Mediterranean, and South Africa. In Taiwan, a Hepatitis B
virus (HBV) and Hepatitis C virus (HCV) epidemic region, HCC
is the leading cause of cancer deaths in males [1]. The incidence of
HCC has also increased in the both United States and the United
Kingdom in the past two decades [1–3]. Prognosis is usually
dismal, and the only known curative therapies are surgical, i.e.,
hepatic resection or liver transplantation. Additionally, the
percentage patients with appropriate indications for surgery are
relatively small [2]. In recent years, studies of surgical treatment
for HCC and other diseases have attempted to develop models for
predicting surgical outcome [4–6]. However, outcome prediction
models with acceptable accuracy have been difficult to develop
[7].
Artificial neural networks (ANNs) are complex and flexible
nonlinear systems with properties not found in other modeling
systems. These properties include robust performance in dealing
with noisy or incomplete input patterns, high fault tolerance, and
the ability to generalize from the input data [8,9]. Although many
different ANNs have been developed, a common feature is an
interconnected group of nodes in multiple layers, in which input
nodes and output nodes have clinical correlates [10]. Hidden
nodes, which connect to inputs and outputs, allow nonlinear
interactions among the input variables and do not have real-world
correlates. The nodes are connected by links, each of which has an
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paired with known outputs, and learning occurs when the weights
between nodes are modified according to feedback [8–10]. The
computational power of an ANN is derived from the distributed
nature of connections. Once a model is trained, prediction outputs
can be generated from novel records [8–10].
Previous comparisons of logistic regression (LR) and ANN
models for predicting outcomes of HCC surgery have shown
major shortcomings [11,12]. Firstly, few have used longitudinal
data for more than two years. Secondly, the data used in most
studies have been for HCC patient populations in the United
States or in Organization for Economic Co-operation and
Development (OECD) countries, which may substantially differ
from those in Taiwan. Thirdly, no studies have considered group
differences in other factors such as age, gender and nonsurgical
treatment. Finally, since most published articles comparing the
performance of ANN models and LR models for predicting HCC
outcomes used only a single dataset, the essential issue of internal
validity (reproducibility) of the models has not been addressed.
Therefore, the primary aim of this study was to validate the use
of ANN models for predicting in-hospital mortality in HCC
surgery patients. The secondary aim was to compare outcome
prediction between ANN and LR models.
Materials and Methods
Ethics Statement
This study analyzed administrative claims data obtained from
the Taiwan Bureau of National Health Insurance (BNHI). Because
the BNHI is the sole payer in Taiwan, the BNHI data set was
assumedly the most comprehensive and reliable data source for the
study. The subjects of this study were recruited by reviewing
monthly patient discharge data released by the BNHI. Further-
more, the database contains a registry of contracted medical
facilities, a registry of board-certified physicians and monthly
summaries for all inpatient claims. Because these were aggregate
secondary data without personal identification, this study was
exempt from full review by the internal review board. The study
protocol conforms to ethical standards according to the Declara-
tion of Helsinki published in 1964. Additionally, the requirement
for written or verbal patients’ consent for this data linkage study
was waived.
Study Population
The study sample included all patients diagnosed with
malignant neoplasm of liver and intrahepatic bile ducts (ICD-9-
CM codes 155.XX) during the years 1998–2009 (n=148,018).
After excluding cases other than those who had received partial
hepatectomy (ICD-9-CM procedure code 50.22) or liver lobecto-
my (ICD-9-CM procedure code 50.3), 24,748 cases remained.
Patients with secondary and unspecified malignant neoplasm
(ICD-9-CM codes 196.XX–199.XX), malignant neoplasm of
intrahepatic bile ducts (ICD-9-CM code 155.1), or malignant
neoplasm of the liver other than a primary or secondary neoplasm
(ICD-9-CM code 155.2) were also excluded, which left a sample of
22,926 eligible subjects with primary liver malignancy who had
received hepatectomies during the study period.
Potential Confounders
The analyzed patient characteristics and hospital characteristics
of the study population included age, gender, co-morbidity,
hospital volume, surgeon volume, length of stay (LOS), and in-
hospital survival. Co-morbidity was estimated using the Charlson
co-morbidity index (CCI) [13]. For each hospital or surgeon, HCC
volume was defined by calculating the percentage of HCC
surgeries in the total surgeries performed by the respective hospital
or surgeon during the study period. Specifically, HCC volume for
a hospital or surgeon was categorized as low, medium, high, and
very high if the number of HCC surgeries performed by the
hospital or surgeon during a given year in the study period
comprised 25%, 26%,50%, 51%,74%, and 75%, respec-
tively, of the total surgical procedures performed by the hospital or
surgeon that year.
Development of the LR model
The dataset was randomly divided into a training set of 18,341
cases (80% of the overall dataset) and a test set of 4,585 cases (20%
of the overall dataset). The training set was used to build the LR
model. Age, gender, CCI, hospital volume, surgeon volume and
LOS were the independent variables, and outcome (death/
survival) was the dependent variable. The LR model was then
tested using the testing dataset. These steps (randomized division
of dataset and regression analysis considering the same variables)
were repeated 1,000 times to obtain 1,000 pairs of training and
testing datasets (80% and 20% of the original dataset, respective-
ly), which were saved for further processing by the neural network.
Development of the ANN model
The ANN used in this study was a standard feed-forward, back-
propagation neural network with three layers: an input layer, a
hidden layer and an output layer. The multilayer perceptron
(MLP) network is an emerging tool for designing special classes of
layered feed-forward networks [14]. Its input layer consists of
source nodes, and its output layer consists of neurons; these two
layers connect the network to the outside world. In addition to
these two layers, the MLP usually has one or more layers of
neurons referred to as hidden neurons because they are not
directly accessible. The hidden neurons extract important features
contained in the input data.
An MLP is usually trained by a back-propagation (BP)
algorithm with forward and backward phases [14]. The BP
learning algorithm is easily implemented, and its linear complexity
in the synaptic weights of the network makes it computationally
efficient. For optimal learning efficiency, the neurons are usually
activated with both anti-symmetric functions (e.g., hyperbolic
tangent function) and non-symmetric functions (e.g., logistic
function). The following cross-validation technique is used to
optimize the time when a MLP network training session ‘‘stops’’.
First, one estimation subset of the examples is used for model
training, and one validation subset is used for evaluating model
performance. The neural network is optimized using a training
data set. A separate test data set is used to halt training to mitigate
over-fitting. The training cycle is repeated until the test error no
longer decreases [15,16].
Statistical analysis
The unit of analysis in this study was the individual HCC
surgical patient. The data analysis was performed in several stages.
Firstly, continuous variables were tested for statistical significance
by one-way analysis of variance (ANOVA), and categorical
variables were tested by Fisher exact analysis. Univariate analyses
were performed to identify significant predictors (p,0.05).
Secondly, the discriminatory power of the models was analyzed
using area under the receiver operating characteristic curves
(AUROCs). Here, discriminatory power refers to the ability of a
model to distinguish those who died from those who survived. A
perfectly discriminating model would assign a higher probability of
death to patients who died than to patients who survived. Thirdly,
Comparison of ANN and LR for In-Hospital Survival
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e35781the relative calibration of the models was compared using the
Hosmer-Lemeshow (H-L) statistic to study the predictive accuracy
of the models over the entire range of severity. The H-L statistic is
a single summary measure of calibration and is based on a
comparison of observed and estimated mortality in patients
grouped by estimated mortality [17]. The lower the H-L statistic,
the better the fit. Therefore, a perfectly calibrated model should
have an H-L value of zero. Finally, sensitivity analysis was
Table 1. Patient characteristics and hospital characteristics (N=22,926).
Variable No. of patients (%)
Operation years
1998–2001 6,857 (29.9)
2002–2005 7,245 (31.6)
2006–2009 8,824 (38.5)
Age [mean 6 standard deviation], years 58.6612.7
Gender
Female 6,028 (26.3)
Male 16,898 (73.7)
Charlson co-morbidity index [mean 6 standard deviation], scores 3.661.6
Hospital volume
Low 4,218 (18.4)
Medium 6,145 (26.8)
High 6,086 (26.6)
Very high 6,477 (28.2)
Surgeon volume
Low 5,250 (22.9)
Medium 5,860 (25.6)
High 5,806 (25.3)
Very high 6,010 (26.2)
Length of stay [mean 6 standard deviation], days 17.869.7
In-hospital mortality
Survival 22,307 (97.3)
Death 619 (2.7)
doi:10.1371/journal.pone.0035781.t001
Table 2. The LR model using selected variables related to in-hospital mortality.
Variable Un-standardized coefficient Standardized error Odds ratio (OR) P value
Age 20.042 0.005 1.04 ,0.001
Gender
a
Male 20.213 0.054 1.24 0.002
Charlson co-morbidity index 20.208 0.027 1.23 ,0.001
Hospital volume
a
Medium 0.284 0.131 1.13 ,0.001
High 0.660 0.265 1.52 ,0.001
Very High 0.719 0.273 1.84 ,0.001
Surgeon volume
a
Medium 0.659 0.143 1.22 ,0.001
High 0.937 0.155 1.79 ,0.001
Very High 1.549 0.215 2.41 ,0.001
Length of stay 20.039 0.004 1.04 ,0.001
Constant 7.267 0.355 2.01 ,0.001
LR=logistic regression.
aReference variables are female gender, low hospital volume, low surgeon volume.
doi:10.1371/journal.pone.0035781.t002
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models. To simplify the training process, key variables were
introduced, and unnecessary variables were excluded. A sensitivity
analysis was also performed to assess the relative significance of
input parameters in the system model and to rank the importance
of the variables. The global sensitivity of the input variables against
the output variable was expressed as the ratio of the network error
(sum of squares of residuals) with a given input omitted to the
network error with the input included. A ratio of 1 or lower
indicates that the variable diminishes network performance and
should be removed.
For every 1000 pairs of ANN models and LR models (trained
and tested on the same datasets) these indices (accuracy rate,
AUROC, and H-L statistic) were calculated and compared using
paired T-tests.
The STATISTICA 10.0 (StatSoft, Tulsa, OK) software was
used to construct the ANN models and LR models of the
relationship between the identified predictors and selected
significant variables (p,0.05).
Results
Table 1 shows the patient characteristics and hospital
characteristics of the study. The mean age of the study population
was 58.6 years (standard deviation 12.7), and 73.7% of the patients
were male. The overall in-hospital mortality rate was 97.3%. The
mean CCI in the study population was 3.6 (standard deviation
1.6). Table 2 shows the coefficients for in-hospital mortality
obtained for the training set in the LR model. In-hospital mortality
had a significant negative association with age, male gender, CCI
and LOS (p,0.05) but a significant positive association with
hospital volume and surgeon volume (p,0.05).
The ANN-based approaches used 3-layer networks and the
relative weights of neurons to predict in-hospital mortality. The
MLP model included 6 inputs (i.e., age, gender, CCI, hospital
volume, surgeon volume, and LOS), 1 bias neuron in the input
layer, 3 hidden neurons, 1 bias neuron in the hidden layer, and 1
output neuron (Figure 1). The activation functions of logistic
sigmoid and hyperbolic tangent are used in each neuron of the
hidden layer and output layer, respectively.
Figure 1. Schematic representation of artificial neural network model with 6 input nodes, 3 nodes in a single hidden layer, and a
single output node representing in-hospital mortality. X1, age; X2, gender; X3, Charlson co-morbidity index; X4, hospital volume; X5, surgeon
volume; X6, length of stay; IB, input layer bias; HB, hidden layer bias.
doi:10.1371/journal.pone.0035781.g001
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terms of discrimination, calibration, and accuracy (cutoff point
0.5). Compared to LR, ANN had a superior accuracy rate in
97.28% of cases, a superior H-L statistic in 41.18% of cases, and a
superior AUROC in 84.67% of cases.
The training data set was also used to calculate the variable
sensitivity ratios (VSR) for the ANN model. Table 4 shows the
VSR values for the outcome variable (in-hospital mortality) in
relation to gender, age, CCI, hospital volume, surgeon volume and
LOS. In the ANN model, surgeon volume was the most influential
(sensitive) parameter affecting in-hospital mortality followed by age
and LOS. All VSR values exceeded 1, which indicated that the
network performed better when all variables were considered.
Table 5 compares the ANN model and LR model in terms of
sensitivity, specificity, positive predictive value (PPV), negative
predictive value (NPV), accuracy rate, and AUROC. Together,
these values confirmed that the ANN model had superior
sensitivity (78.40% versus 62.64%), specificity (94.57% versus
91.92%), PPV (84.22% versus 76.65%), NPV (96.91% versus
87.18%), accuracy rate (95.93% versus 84.47%) and AUROC
(0.82 versus 0.73).
Discussion
The comparison of prediction models in this study showed that
accuracy in predicting in-hospital mortality was significantly
higher in the ANN model than in the LR model (p,0.001). To
our knowledge, this study is the first to use a nationwide
population-based database to train and test a neural network for
predicting HCC surgery outcome. The neural network model was
compared with actual outcomes and with an LR model
constructed using identical inputs. Given a limited number of
clinical inputs and a specific outcome measure, the ANN model
consistently outperformed the LR model.
Whereas other prediction models have used data for a single
medical center, the prediction model in this study was constructed
using national registry data from the Taiwan BNHI. Therefore, it
gives a better overview of current outcomes of HCC surgery in an
HBV and HCV epidemic region. Compared to data obtained by
single-center series studies, data from registry studies provide a
better overview of practices in large populations while avoiding
referral bias or bias reflecting the practices of individual surgeons
or institutions [18,19].
Because ANNs use a dynamic approach to analyzing mortality
risk, they can modify their internal structure in relation to a
functional objective by bottom-up computation (i.e., by using the
data themselves to generate the model). Although they cannot deal
with missing data, ANNs can simultaneously handle numerous
variables by building models with reference to outliers and
nonlinear interactions among variables [8–10]. Whereas conven-
tional statistical methods reveal parameters that are significant
only for the overall population, ANNs include parameters that are
significant at the individual level even if they are not significant for
the overall population. Unlike other standard statistical tests,
ANNs can also manage complexity even when the sample size is
small and even when the ratio between variables and records is
unbalanced [8–10]. That is, ANNs avoid the dimensionality
problem. The large and homogeneous dataset in this study
enabled robust network training because all clinical variables had
shown potential impacts on mortality in previous LR models
[7,20].
Chen et al. showed that ANN combined with genetic algorithm
can identify clinically significant variables and can precisely
predict Tacrolimus blood concentrations in liver transplantation
patients [21]. In a comparison of ANN and LR models for
predicting cirrhosis in chronic hepatitis C patients, Cazzaniga et
al. also showed that the ANNs were slightly more accurate and
more reproducible [20]. Recently, Cucchetti et al showed that
ANN is more accurate than conventional LR for identifying HCC
tumor grade and microscopic vascular invasion based on
preoperative variables and is preferable to LR for tailoring clinical
management [5].
The ANN approach developed in this study extends the
predictive range of the LR model by replacing identity functions
with nonlinear activation functions. The approach is apparently
superior to linear regression for describing systems. The ANNs
may be trained with data acquired in various clinical contexts and
can consider local expertise, racial differences, and other variables
with uncertain effects on clinical outcome [8–10]. The analysis is
not limited to clinical parameters. Other variables could be tested
for use in improving the predictive accuracy of the model. The
proposed ANN architecture can also include more than one
dependent variable and can perform a non-linear transformation
between dependent variables. Future studies may evaluate how
other patient characteristics or clinical characteristics affect the
proposed architecture.
Throughout this nationwide population-based study, the best
single predictor of in-hospital mortality was surgeon volume,
which was consistent with the results of other reports that high-
volume surgeons consistently achieve superior outcomes of
hepatectomy for HCC [22,23]. Therefore, their treatment
strategies should be carefully analyzed and emulated. If in-hospital
mortality is considered a benchmark, surgeon volume, which is a
major predictor of postoperative outcome, is crucial. Clearly,
outcomes of surgical procedures depend not only on patient
management, but also on the skill and experience of individual
surgeons. Meanwhile, high-volume surgeons in high-volume
hospitals are most likely to achieve good patient outcomes because
they are assisted by highly skilled and interdisciplinary care teams
[22,23].
Table 3. Comparison of 1000 pairs of ANN and LR models for
predicting in-hospital mortality.
Performance
indices ANN (95% C.I.) LR (95% C.I.) P value
Accuracy rate 97.28 (95.88, 98.68) 88.29 (86.49, 90.09) ,0.001
H-L statistics 41.18 (34.67, 47.68) 54.53 (49.53, 59.52) ,0.001
AUROC 0.84 (0.88, 0.80) 0.76 (0.71, 0.81) ,0.001
ANN=artificial neural network; LR=logistic regression; Hosmer-Lemeshow
statistics=H-L statistics; AUROC=area under the receiver operating
characteristic.
doi:10.1371/journal.pone.0035781.t003
Table 4. Global sensitivity analysis of the ANN model in
predicting in-hospital mortality.
Rank
First Second Third
Variable Surgeon volume Age Lengths of stay
VSR 1.22 1.10 1.09
ANN=artificial neural network; VSR=variable sensitivity ratio.
doi:10.1371/journal.pone.0035781.t004
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database analysis. Firstly, the clinical picture obtained in this
analysis of claims data is not as precise as that of a prospective
analysis of clinical trial data due to possible errors in the coding of
primary diagnoses and surgical modalities. Secondly, complica-
tions associated with HCC surgical procedures were not assessed,
which limits the validity of the comparison. Finally, only LR and
ANN models were used to predict in-hospital mortality after HCC
surgery. The database could not be used to predict other outcomes
such as patient-reported quality of life. However, given the robust
magnitude of the effects and the statistical significance of the
effects observed in this study, these limitations are unlikely to
compromise the results.
In conclusion, compared with the conventional LR model, the
ANN model in this study was more accurate in predicting in-
hospital mortality and had higher overall performance indices.
The global sensitivity analysis also showed that surgeon volume
was the best predictor of in-hospital mortality after HCC surgery.
The predictors analyzed in this study could be addressed by
healthcare professionals during preoperative and postoperative
health care consultations with candidates for HCC surgery to
educate them in the expected course of recovery and health
outcomes. Further studies of this model may consider the effect of
a more detailed database that includes complications and clinical
examination findings as well as more detailed outcome data.
Hopefully, the model will evolve into an effective adjunctive
clinical decision making tool.
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